Results 1 to 10 of about 91,577 (211)

Intravitreal Bevacizumab plus Methotrexate for iris and ciliary body metastasis from lung cancer [PDF]

American Journal of Ophthalmology Case Reports
Purpose: To describe a case of iris and ciliary body metastasis from lung adenocarcinoma responding to intravitreal bevacizumab and methotrexate. Observations: A 66-year-old man presented with an amelanotic vascular lesion of the iris and ciliary body (7 
Thaís Marino de Azeredo Bastos, Igor Neves Coelho, Leticia Audi, Fernando Chahud, Marco Folgosa, Zelia Maria Correa, Rodrigo Jorge   +6 more
doaj   +2 more sources

Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population [PDF]

Renal Failure
Many studies have investigated the ocular benefits of intravitreal bevacizumab but there is scarcity of literature evaluating the effects of bevacizumab on kidney function and proteinuria especially in the Asian population. This study aims to investigate
Brajesh Mourya, Sukhwinder Singh Sangha, Asheesh Kumar, Timitrov P, Raj Kanwar Yadav, Dipankar Bhowmik, Sanjay Kumar Agarwal, Rajesh Sinha, Shorya Vardhan Azad   +8 more
doaj   +2 more sources

Intravitreal bevacizumab

Indian Journal of Ophthalmology, 2018
While supervised, graded surgeries, some wet laboratory exposure, postoperative evaluation of patients, and documentation of records is stressed on routinely, we have tried to make the learning process more fun and interactive at our institute by ...
Smita Praveen
semanticscholar   +4 more sources

INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF CHOROIDAL HEMANGIOMAS. [PDF]

Retina
Purpose: To investigate the use of intravitreal bevacizumab for the treatment of subretinal fluid (SRF) and intraretinal fluid associated with circumscribed choroidal hemangiomas. Methods: This was a retrospective review of all patients treated with at least three bevacizumab ...
Elkayal HE, Sagoo MS, Negretti GS.
europepmc   +3 more sources

Safety of an Intravitreal Bevacizumab Biosimilar (MVASI). [PDF]

Clin Exp Ophthalmol
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021.
Wang H, Bahrami B, Huang S, Tahmasebi Sarvestani M, Cugati S, Lake S, Chan WO, Supramaniam D, Little M.   +8 more
europepmc   +3 more sources

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity

Journal of Ophthalmology, 2015
Purpose. This study aims to evaluate the regression of retinopathy of prematurity (ROP) after one intravitreal injection of bevacizumab and the factors that influenced it. Methods.
Simona Delia Nicoară, Constanța Nascutzy, Cristina Cristian, Iulian Irimescu, Anne Claudia Ștefănuț, Gabriela Zaharie, Tudor Drugan   +6 more
doaj   +2 more sources

Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy

Theranostics, 2023
Diabetic retinopathy (DR) is associated with retinal neovascularization, hard exudates, inflammation, oxidative stress and cell death, leading to vision loss.
S. Reddy, Abhijna Ballal, S. Shailaja, R. Seetharam, Chandrashekar H Raghu, R. Sankhe, K. Pai, Tenzin Tender, M. Mathew, A. Aroor, Ashok K. Shetty, S. Adiga, V. Devi, Manjunatha S. Muttigi, D. Upadhya   +14 more
semanticscholar   +1 more source

Use of Intravitreal Bevacizumab Injection among Patients Undergoing Surgical Retinal Interventions at Tertiary Eye Hospital: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2021
Introduction: Intravitreal Bevacizumab injection has now become a routine procedure for retina specialists throughout the world. Easy availability of this monoclonal antibody molecule even in Nepal has brought a revolution in the management of various ...
Arjun Shrestha, Rinkal Suwal, Rajan Shrestha, Barsha Suwal, Deepak Khadka   +4 more
doaj   +1 more source

CENTRAL MACULAR THICKNESS AFTER COMBINED THERAPY OF BEVACIZUMAB INTRAVITREAL INJECTION AND TOPICAL DICLOFENAC COMPARED WITH BEVACIZUMAB INTRAVITREAL INJECTION ALONE IN DIABETIC MACULAR EDEMA

IJRETINA (International Journal of Retina), 2021
Introduction: To evaluate whether the combination of diclofenac eye drops and bevacizumab intravitreal injection would provide additional benefits over bevacizumab alone in the treatment of naïve diabetic macular edema (DME).
Melvina Nidya Sandra, Yumni Shabrina, Tri Wahyu Widayanti, Retno Ekantini, Agus Supartoto, Muhammad Bayu Sasongko, Supanji Haryanto   +6 more
doaj   +1 more source

Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab [PDF]

International Journal of Ophthalmology, 2020
AIM: To identify risk factors for an atherothrombotic event (ATE) among patients who were treated for diabetic macular edema (DME) with intravitreal bevacizumab injections. METHODS: This retrospective study enrolled all consecutive patients with DME who
Alon Tiosano, Aviel Hadad, Noam Yanculovic   +2 more
doaj   +1 more source